These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6383363)

  • 1. Estimation of individually adapted control parameters for an artificial beta cell.
    Salzsieder E; Albrecht G; Jutzi E; Fischer U
    Biomed Biochim Acta; 1984; 43(5):585-96. PubMed ID: 6383363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the glucose-insulin system as a basis for the artificial beta cell.
    Fischer U; Salzsieder E; Jutzi E; Albrecht G; Freyse EJ
    Biomed Biochim Acta; 1984; 43(5):597-605. PubMed ID: 6383364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of a glucose appearance function from foods using deconvolution.
    Yates TL; Fletcher LR
    IMA J Math Appl Med Biol; 2000 Jun; 17(2):169-84. PubMed ID: 10994512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model-based system for the individual prediction of metabolic responses to improve therapy in type I diabetes.
    Salzsieder E; Fischer U; Stoewhas H; Thierbach U; Rutscher A; Menzel R; Albrecht G
    Horm Metab Res Suppl; 1990; 24():10-9. PubMed ID: 2272613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.
    Kerner W; Thum C; Tamás G; Beischer W; Clemens AH; Pfeiffer EF
    Horm Metab Res; 1976 Jul; 8(4):256-61. PubMed ID: 783030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
    Asakawa N; Saito Y; Yamasaki Y; Kawamori R; Shichiri M
    Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell.
    Freyse EJ; Fischer U; Albrecht G
    Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-based blood glucose control for Type 1 diabetes via parametric programming.
    Dua P; Doyle FJ; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1478-91. PubMed ID: 16916082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell.
    Abel P; Müller A; Fischer U
    Biomed Biochim Acta; 1984; 43(5):577-84. PubMed ID: 6477543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of different control techniques for the regulation of blood glucose level in diabetic patients.
    Ibbini MS
    J Med Eng Technol; 2009; 33(8):656-62. PubMed ID: 19848860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
    Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A robust controller for insulin pumps based on H-infinity theory.
    Kienitz KH; Yoneyama T
    IEEE Trans Biomed Eng; 1993 Nov; 40(11):1133-7. PubMed ID: 8307597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and insulin dynamics in the anaesthetized dog: a mathematical modeling study.
    Tiran J; Broekhuyse H; Albisser AM
    Med Prog Technol; 1980 Sep; 7(4):183-92. PubMed ID: 7003341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal H infinity insulin injection control for blood glucose regulation in diabetic patients.
    Chee F; Savkin AV; Fernando TL; Nahavandi S
    IEEE Trans Biomed Eng; 2005 Oct; 52(10):1625-31. PubMed ID: 16235648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus.
    Owens C; Zisser H; Jovanovic L; Srinivasan B; Bonvin D; Doyle FJ
    IEEE Trans Biomed Eng; 2006 Jun; 53(6):996-1005. PubMed ID: 16761826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.